<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Annals of the Russian academy of medical sciences</journal-id><journal-title-group><journal-title xml:lang="en">Annals of the Russian academy of medical sciences</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник Российской академии медицинских наук</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0869-6047</issn><issn publication-format="electronic">2414-3545</issn><publisher><publisher-name xml:lang="en">"Paediatrician" Publishers LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">316</article-id><article-id pub-id-type="doi">10.15690/vramn.v67i4.195</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>CARDIOLOGY: CURRENT ISSUES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>АКТУАЛЬНЫЕ ВОПРОСЫ КАРДИОЛОГИИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">ROLE OF ENDOTHELIUM IN REMODELLING A MYOCARDIUM LEFT VENTRICULAR AT PATIENTS ON A HEMODIALYSIS</article-title><trans-title-group xml:lang="ru"><trans-title>РОЛЬ ЭНДОТЕЛИЯ В РЕМОДЕЛИРОВАНИИ МИОКАРДА ЛЕВОГО ЖЕЛУДОЧКА У БОЛЬНЫХ НА ГЕМОДИАЛИЗЕ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kharlamova</surname><given-names>U. V.</given-names></name><name xml:lang="ru"><surname>Харламова</surname><given-names>У. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>кандидат медицинских наук, ассистент кафедры внутренних болезней и военно- полевой терапии ГБОУ ВПО «Челябинская государственная медицинская академия» Минздравсоцразвития России Адрес: 454007, Челябинск, пр-т Ленина, д. 19, кв. 4 Тел.: 8(912) 472-38-20</p></bio><email>top120@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Il'icheva</surname><given-names>O. E.</given-names></name><name xml:lang="ru"><surname>Ильичева</surname><given-names>О. Е.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>доктор медицинских наук, профессор кафедры внутренних болезней и военно- полевой терапии, декан лечебного факультета ГБОУ ВПО «Челябинская государственная медицинская академия» Минздравсоцразвития России Адрес: 454080, Челябинск, пр-т Ленина, д. 65, кв. 75</p></bio><email>pochka56@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Сhelyabinsk state medical academy of Federal agency on public health services and social development</institution></aff><aff><institution xml:lang="ru">ГБОУ ВПО «Челябинская государственная медицинская академия» Минздравсоцразвития России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2012-04-23" publication-format="electronic"><day>23</day><month>04</month><year>2012</year></pub-date><volume>67</volume><issue>4</issue><issue-title xml:lang="en">Vestnik Rossiiskoi akademii medetsinskikh nauk / Annals of the Russian academy of medical sciences</issue-title><issue-title xml:lang="ru">Вестник Российской академии медицинских наук</issue-title><fpage>25</fpage><lpage>29</lpage><history><date date-type="received" iso-8601-date="2015-08-07"><day>07</day><month>08</month><year>2015</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2012, "Paediatrician" Publishers LLC</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2012, Издательство "Педиатръ"</copyright-statement><copyright-year>2012</copyright-year><copyright-holder xml:lang="en">"Paediatrician" Publishers LLC</copyright-holder><copyright-holder xml:lang="ru">Издательство "Педиатръ"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://vestnikramn.spr-journal.ru/jour/article/view/316">https://vestnikramn.spr-journal.ru/jour/article/view/316</self-uri><abstract xml:lang="en"><p><italic>To study influence of markers of function endothelium on structurally functional indicators left ventricular at patients on a hemodialysis.. 98 patients on a hemodialysis are surveyed. To all patients defined concentration stable metabolites of oxyde nitrogen whey of blood, total cholesterol, cholesterol of low density lipoproteine, cholesterol of high density lipoproteine, triglycerides, homocysteine, Willebrand factor, spent echocardiography research. During correlation, multiple regression the analysis independent influence of indicators of function endothelium on structurally functional indicators of a myocardium left ventricular, processes of formation of dysfunction of heart reflecting parallelism and endothelium is revealed</italic></p><p> </p></abstract><trans-abstract xml:lang="ru"><p><italic>Изучалось влияние маркеров функции эндотелия на структурно-функциональные показатели левого желудочка у 98 больных, находящихся на гемодиализе. Определяли концентрации стабильных метаболитов оксида азота сыворотки крови, общего холестерина, липопротеинов высокой и низкой плотности, триглицеридов, гомоцистеина, фактора Виллебранда. При помощи корреляционного и многофакторного регрессионного анализа установлено независимое влияние показателей функции эндотелия на структурно-функциональные показатели миокарда левого желудочка, что отражает параллельность процессов формирования дисфункции сердца и эндотелия</italic></p><p> </p></trans-abstract><kwd-group xml:lang="en"><kwd>hemodialysis</kwd><kwd>endothelium</kwd><kwd>myocardium remodelling</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>гемодиализ</kwd><kwd>эндотелий</kwd><kwd>ремоделирование миокарда</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>1. Buval’cev V.I., Kamyshova T.V., Spasskaya M.B. i dr. Disfunkciya `endoteliya kak integral’nyj faktor riska ateroskleroza i vozmozhnosti ee korrekcii. Klinicheskaya farmakologiya i terapiya. 2002; 11(5): 30–32.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>2. Zagidullin N.Sh., Valeeva K.F., Gassanov N. i dr. Znachenie disfunkcii `endoteliya pri serdechno-sosudistyh zabolevaniyah i metody ee medikamentoznoj korrekcii . Kardiologiya. 2010; 5: 54–60.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>3. Bostom A., Brosnan J.T., Hall B. Net uptake of plasma homocysteine by the rat kidney in vivo. Atherosclerosis. 1995; 116: 59–62.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>4. Smirnov A.V., Esayan A.M., Kayukov I.G. i dr. Sovremennye podhody k zamedleniyu progressirovaniya hronicheskoj bolezni pochek. Nefrologiya. 2004; (3): 89–99.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>5. Hoenicb N.A. Platelet and leucocytes behaviour during haemodialysis. Contrib. Nephrol. 1999; 125: 120–132.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>6. Lang D., Kredan M.B., Lang D., Moat S.J. et al. Homocysteineinduced inhibition of endothelium-dependent relaxation in rabbit aorta: Role for superoxide anions. Arterioscler. Thromb. Vasc. Biol. 2000; 5: 257–261.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>7. Dyadyk A.I., Kanella Dzh., Bagrij A.`E. i dr. Gipertrofiya levogo zheludochka serdca u bol’nyh s hronicheskoj pochechnoj nedostatochnost’yu. Ukr. kardiol. zhurn. 2000; 3: 81–87.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>8. Kremneva L.V., Shalaev S.V. Modificirovannye lipoproteiny nizkoj plotnosti: aterogennaya i provospalitel’naya aktivnost’, rol’ v patogeneze ostryh koronarnyh sindromov Ross. Kardiol. Zhurnal. 2004; 46 (2): 70–75.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>9. Manuhina E.B., Malyshev I.Yu. Rol’ oksida azota v serdechnososudistoj patologii: vzglyad patofiziologa. Ross. kard. Zhurn. 2000; 5: 55–63.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>10. Belenkov Yu.N. Remodelirovanie levogo zheludochka: kompleksnyj podhod. Serdechnaya nedostatochnost’. 2002; 4 (14): 161–163.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>11. Nasonov E.L., Baranov A.A., Shilkina N.P. Markery aktivacii `endoteliya (trombomodulin, antigen faktora Villebranda i angiotenzinprevraschayuschij ferment): klinicheskoe znachenie. Klinicheskaya medicina. 1998; 11: 4–9.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>12. Liu X., Luo F., Li J. et al. Homocysteine induces connective tissue grows factor expression in vascular smooth muscle cells. J Thromb. Haemost. 2008; 6 (1): 184–192.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>13. Zang C., Cai Y., Adachi M.T. Homocysteine induces programmed cell death in human vascular endothelial cells through activation of the unfolder protein response. J. Biol. Chem. 2001; 276: 35867– 35874.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>14. Korandji C., Zeller M., Guilland J.C. et al. Asymmetric dimethylarginine (ADMA) and hyperhomocysteinemia in patients with acute myocardial infarction. Clin. Biochem. 2007; 40 (1-2): 66–72.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>15. Ageev F.T., Ovchinnikov A.G. Diastolicheskaya disfunkciya kak proyavlenie remodelirovaniya serdca. Serdechnaya nedostatochnost’. 2002; 4 (14): 190–195.</mixed-citation></ref></ref-list></back></article>
